SAN CARLOS, Calif., October 27, 2021 – BigHat Biosciences, a novel protein therapeutics company and developer of an AI-guided antibody design platform, today announced it has been selected as winner of the “Therapeutics Innovation of the Year” award in the inaugural BioTech Breakthrough Awards program conducted by BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies around the globe.
“We are honored to receive this recognition in the inaugural BioTech Breakthrough Awards, which will help us pursue our mission to improve human health by making it far easier to design advanced, next-generation antibody therapeutics,” said Dr. Mark DePristo, PhD, Co-founder and CEO of BigHat. “Our robust and flexible platform gives us the ability to partner with companies anywhere along the therapeutic development continuum as well as drive internal programs to address major unmet needs across a variety of indications. All of this enables us to capture a wealth of data to continuously improve our AI/ML models and wet lab techniques.”
The mission of the annual BioTech Breakthrough Awards program is to conduct the industry’s most comprehensive analysis and evaluation of the top technology companies, solutions and products in the life sciences and biotechnology industry today. This year’s program attracted more than 1,200 nominations from over 12 different countries throughout the world.
“Biologics represented eight of the ten top selling drugs in 2019 due to their transformative treatment to some of our most intractable diseases such as cancer and immunological disorders. There has been increasing excitement to develop novel approaches to antibody therapeutic design that can overcome the limitations of the traditional monoclonal antibodies and older technologies,” said Bryan Vaughn, Managing Director of BioTech Breakthrough Awards. “BigHat has become a leader among companies applying AI to design therapeutic antibodies. Along with Dr. DePristo, an AI expert in bioinformatics, BigHat has assembled a world-class team of protein engineers, computer scientists, software engineers, AI/ML experts and executives. Congratulations on being our choice for the ‘Therapeutics Innovation of the Year’ award.”
About BioTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the BioTech Breakthrough Awards program is devoted to honoring excellence in life science and biotechnology solutions, services and companies. The BioTech Breakthrough Awards provide public recognition for the achievements of biotechnology companies and products in categories including BioPharma, Genomics, Therapeutics, Food Science and BioAgriculture, and more. For more information visit BioTechBreakthroughawards.com
